Summaries & Highlights

2024 SABCS Annual Meeting Insights Hub

SABCS 2024 Summary: eBC Highlights Including GeparDouze & OlympiA

FEATURING Sara Tolaney, Hope Rugo
  • 10 views
  • December 22, 2024
  • 2

2024 SABCS Annual Meeting Insights Hub

SABCS 2024 Summary: Innovative Immunotherapy Approaches in Breast Cancer

FEATURING Heather McArthur
  • 71 views
  • December 19, 2024
  • 3

2024 SABCS Annual Meeting Insights Hub

SABCS 2024 Summary: mBC Key Trial Highlights Including PATINA and EMBER-3

FEATURING Adam Brufsky
  • 168 views
  • December 18, 2024
  • 5

2024 SABCS Annual Meeting Insights Hub

SABCS 2024 Summary: Addressing Pathologic and Therapeutic Challenges in Lobular Breast Cancer

FEATURING Laszlo Tabar
  • 155 views
  • December 17, 2024
  • 5

2024 SABCS Annual Meeting Insights Hub

SABCS 2024 Summary: Updates on Next-Generation PI3K Inhibitors for Advanced Breast Cancer

FEATURING Christos Vaklavas
  • 105 views
  • December 17, 2024
  • 4

HR+

2024 SABCS Annual Meeting Insights Hub

SABCS 2024 Insights: DESTINY-Breast06 - Monday Morning Practice

FEATURING Sara Tolaney, Hope Rugo
  • 5 views
  • December 22, 2024
  • 1

2024 SABCS Annual Meeting Insights Hub

SABCS 2024 Insights: PATINA - Monday Morning Practice

FEATURING Sara Tolaney, Hope Rugo
  • 88 views
  • December 22, 2024
  • 6

2024 SABCS Annual Meeting Insights Hub

SABCS 2024 Insights: PADMA - Monday Morning Practice

FEATURING Sara Tolaney, Hope Rugo
  • 64 views
  • December 22, 2024
  • 3

HER2-Low

2024 SABCS Annual Meeting Insights Hub

SABCS 2024 Insights: DESTINY-Breast06 - Monday Morning Practice

FEATURING Sara Tolaney, Hope Rugo
  • 5 views
  • December 22, 2024
  • 1

HER2+

2024 SABCS Annual Meeting Insights Hub

SABCS 2024 Insights: PATINA - Monday Morning Practice

FEATURING Sara Tolaney, Hope Rugo
  • 88 views
  • December 22, 2024
  • 6

2024 SABCS Annual Meeting Insights Hub

SABCS 2024 Insights: Effectiveness of Post-T-DXd Treatments in HER2+ mBC - EN-SEMBLE Study

FEATURING Kazuki Nozawa
  • 3 views
  • December 20, 2024

2024 SABCS Annual Meeting Insights Hub

SABCS 2024 Insights: EmpowHER 303 - Zanidatamab vs. Trastuzumab + Chemo in HER2+ mBC Post-T-DXd

FEATURING Sara Tolaney
  • 2 views
  • December 17, 2024

Triple-Negative Breast Cancer (TNBC)

No available content for Triple-Negative Breast Cancer (TNBC), yet.

Other Videos

2024 SABCS Annual Meeting Insights Hub

SABCS 2024 Summary: eBC Highlights Including GeparDouze & OlympiA

FEATURING Sara Tolaney, Hope Rugo
  • 10 views
  • December 22, 2024
  • 2

2024 SABCS Annual Meeting Insights Hub

SABCS 2024 Insights: EMBER-3 - Monday Morning Practice

FEATURING Sara Tolaney, Hope Rugo
  • 45 views
  • December 22, 2024
  • 1

2024 SABCS Annual Meeting Insights Hub

SABCS 2024 Summary: Innovative Immunotherapy Approaches in Breast Cancer

FEATURING Heather McArthur
  • 71 views
  • December 19, 2024
  • 3

2024 SABCS Annual Meeting Insights Hub

SABCS 2024 Summary: mBC Key Trial Highlights Including PATINA and EMBER-3

FEATURING Adam Brufsky
  • 168 views
  • December 18, 2024
  • 5

2024 SABCS Annual Meeting Insights Hub

SABCS 2024 Summary: Addressing Pathologic and Therapeutic Challenges in Lobular Breast Cancer

FEATURING Laszlo Tabar
  • 155 views
  • December 17, 2024
  • 5

2024 SABCS Annual Meeting Insights Hub

SABCS 2024 Summary: Updates on Next-Generation PI3K Inhibitors for Advanced Breast Cancer

FEATURING Christos Vaklavas
  • 105 views
  • December 17, 2024
  • 4